Roche (RHHBY) announced that it will present new data at the Muscular Dystrophy Association, MDA conference, 16-19 March, 2025, in Dallas, ...

It's hard watching a former local darling get restructured, but federal funding blocks and a lack of local investors are more front-of-mind.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Tecno Mobile has announced its Spark Slim, an ultra-thin concept smartphone set to debut at Mobile World Congress in Barcelona next week. The Spark Slim features a 6.78-inch 3D curved AMOLED ...

Whether nestled inside shopping malls, perched atop schools or integrated into urban settings, these vibrant designs spark children's imaginations and prove that play knows no bounds. American ...

and continues to advance these capabilities through partnerships with Roche/Spark Therapeutics and Bayer/BlueRock Therapeutics. This press release contains certain statements that are not ...

Roivant, the source of Roche’s TL1A prospect, reported a 21% delta compared to placebo after 12 weeks. Prometheus Biosciences, which Merck acquired, saw a 31% placebo-adjusted rate of endoscopic ...

Spark has lost $1 billion in market value as investors punished the company for its poor results. Its share price closed down 19 percent to $2.38, valuing the company at $4.39b, down from $5.4b at ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...

Spark's half-year profit has fallen by more than three-quarters, with the company blaming the country's deep recession for its tough result. Key numbers for the six months ended December compared with ...